Status:
COMPLETED
Mindfulness Intervention for Post-Covid Symptoms
Lead Sponsor:
Mayo Clinic
Conditions:
COVID-19
Post Acute Sequelae of SARS-CoV-2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the feasibility of using a wearable brain-sensing wellness device (Muse-S) to potentially reduce stress and anxiety during Post-Covid, which is characterized by ...
Detailed Description
This study will answer the following questions: 1) will patients experiencing Long-Covid Syndrome utilize a wearable brain-sensing wellness device to potentially reduce stress and anxiety 2) does usin...
Eligibility Criteria
Inclusion
- Identified with one of 3 Post-Covid Syndrome (PASC) phenotypes at Mayo Clinic Rochester.
- Not pregnant by subject self-report at time of consent.
- Have the ability to provide informed consent.
- Have the ability to complete all aspects of this trial.
- Have access to an iPhone, iPad, or Android device.
- Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-SÔ system, as determined by the clinical investigators.
Exclusion
- Used an investigational drug within the past 30 days.
- Anyone that is not on a stable dose of medication for anxiety, depression or sleep.
- Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis.
- Currently (within 3 weeks) has been enrolled in another clinical or research program which intervenes on the patients' QOL, or stress.
- An unstable medical or mental health condition as determined by the physician investigator.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05199233
Start Date
June 1 2022
End Date
December 31 2024
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905